Target intelligence / Profile preview

Extracellular matrix and dermal tissue microenvironment (ECM)

Target
ECM
Molecular classification
Complex biological system, Extracellular matrix, Other
01

Overview

The extracellular matrix (ECM) and dermal tissue microenvironment represent the complex structural and functional network surrounding cells in the skin's dermis (StatPearls, NBK441922). It is composed of fibrous proteins like collagen and elastin, as well as glycosaminoglycans and proteoglycans that provide mechanical strength and hydration (PubMed, 28435139). Beyond structural support, this microenvironment acts as a reservoir for growth factors and a scaffold for cell signaling, influencing cell proliferation, migration, and differentiation (PubMed, 30110464). In disease states, such as fibrosis or cancer, the ECM undergoes remodeling that can promote pathological progression or resistance to therapy (PubMed, 24603150). While not a single molecular target, various components within this environment are targeted by dermatological and aesthetic treatments to address aging, scarring, and wound repair (PubChem, CID 5282371). For instance, collagenase is used to break down excessive collagen in fibrotic conditions, while retinoids are employed to stimulate matrix production in aging skin (PubMed, 10633670).

Other names
Dermal extracellular matrixSkin microenvironmentDermal matrixExtracellular matrix of the dermis
02

Mechanism of action

Modulation of matrix synthesis, enzymatic degradation of structural proteins, or alteration of the signaling environment within the dermis.

03

Biological functions

Structural supportCell adhesionSignal transductionTissue homeostasisWound healingImmune response
04

Disease associations

Skin agingFibrosisSclerodermaMelanoma metastasisChronic woundsCancerInflammation
05

Safety considerations

Risk of fibrosisImpaired wound healingHypersensitivity to enzymatic treatmentsOff-target tissue degradation
06

Interacting drugs

Collagenase clostridium histolyticum

4 more in the full profile.

07

Biomarkers

Collagen type I/III ratioMatrix metalloproteinase-1 (MMP-1) levelsProcollagen type I N-terminal propeptide (PINP)Elastin content

Beyond the preview

Go deeper on Extracellular matrix and dermal tissue microenvironment (ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix and dermal tissue microenvironment (ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call